Zura Bio Limited Class A Ordinary Shares (ZURA) is a publicly traded Healthcare sector company. As of August 11, 2026, ZURA trades at $5.74 with a market cap of $566.66M and a P/E ratio of -5.34. ZURA moved +2.13% today. Year to date, ZURA is +7.44%; over the trailing twelve months it is +296.48%. Its 52-week range spans $0.97 to $7.44. Analyst consensus is strong buy with an average price target of $19.00. Rallies surfaces ZURA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
4 analysts cover ZURA: 0 strong buy, 4 buy, 0 hold, 0 sell, and 0 strong sell. The consensus rating is strong buy. The average price target is $19.00.
| Metric | Value |
|---|---|
| Price | $5.74 |
| Market Cap | $566.66M |
| P/E Ratio | -5.34 |
| EPS | $-1.06 |
| Dividend Yield | 0.00% |
| 52-Week High | $7.44 |
| 52-Week Low | $0.97 |
| Volume | 345.39K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-68.65M |
| Gross Margin | 0.00% |
4 analysts cover ZURA: 0 strong buy, 4 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $19.00.